{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-23-002402","form_type":"8-K","ticker":"MCAG","cik":"0001859035","company_name":"Mountain Crest Acquisition Corp. V","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.214273+00:00","generated_at":"2026-06-17T09:44:40.555013+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mountain Crest Acquisition Corp. V amends business combination agreement with AUM Biosciences","bullets":["Amendment No. 2 removes SPAC's net tangible assets closing condition and eliminates SPAC's right to designate a Holdco board director.","Company Interests updated from 8,779,752 to 9,841,118 Company Ordinary Shares as of Amalgamation Effective Time.","Parties consent to termination of stock escrow agreement dated November 21, 2021.","Outside Date previously extended to May 15, 2023; no change to deal value or structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-23-002402","json":"https://secwatch.observer/filing/0001829126-23-002402.json","markdown":"https://secwatch.observer/filing/0001829126-23-002402.md","text":"https://secwatch.observer/filing/0001829126-23-002402.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859035/000182912623002402/0001829126-23-002402-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859035/000182912623002402/mountaincrest5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:44:40.555013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}